Global burden, point sources, and outbreak management of healthcare-associated


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 23 5 2020
medline: 18 8 2021
entrez: 23 5 2020
Statut: ppublish

Résumé

To examine the global burden, associated point sources, and successful prevention and control measures for documented outbreaks of Burkholderia cepacia healthcare-associated infections (HAIs). Integrative review. A review of all outbreaks of Burkholderia cepacia HAIs published in the peer-reviewed literature between January 1970 and October 2019 was conducted to identify the global burden, associated point sources, and successful prevention and control measures using the Guidelines for Outbreak Reports and Intervention Studies of Nosocomial Infections (ORION). In total, we reviewed 125 documented outbreaks of Burkholderia cepacia-related HAIs worldwide. The reported B. cepacia HAIs for this period involved 3,287 patients. The point sources were identified in most outbreaks of B. cepacia HAIs (n = 93; 74.4%); they included medication vials, disinfectants, and antiseptics. Moreover, 95 of the outbreak reports (76%) described effective prevention and control measures, but only 33 reports indicated the use of a combination of environment-, patient- and staff-related measures. None of the outbreak reports used the ORION guidelines. Outbreaks of Burkholderia cepacia HAIs are an ongoing challenge. They are often associated with immunocompromised patients who acquire the infection from exposure to contaminated medications, products, and equipment. These outbreaks are not infrequent, and a range of infection prevention and control measures have been effective in arresting spread. The use of ORION guidelines for outbreak reporting would improve the quality of information and data to generate evidence for translation into practice.

Identifiants

pubmed: 32441235
pii: S0899823X20001841
doi: 10.1017/ice.2020.184
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

777-783

Auteurs

Ramon Z Shaban (RZ)

Susan Wakil School of Nursing and Midwifery, University of Sydney, Camperdown, New South Wales, Australia.
Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Camperdown, New South Wales, Australia.
Department of Infectious Diseases and Sexual Health, Westmead Hospital and the Directorate of Nursing, Midwifery and Clinical Governance, Western Sydney Local Health District, Westmead, New South Wales, Australia.

Cristina Sotomayor-Castillo (C)

Susan Wakil School of Nursing and Midwifery, University of Sydney, Camperdown, New South Wales, Australia.
Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Camperdown, New South Wales, Australia.

Shizar Nahidi (S)

Susan Wakil School of Nursing and Midwifery, University of Sydney, Camperdown, New South Wales, Australia.
Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Camperdown, New South Wales, Australia.

Cecilia Li (C)

Susan Wakil School of Nursing and Midwifery, University of Sydney, Camperdown, New South Wales, Australia.
Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Camperdown, New South Wales, Australia.

Deborough Macbeth (D)

Infection Control Department, Infectious Diseases and Immunology, Gold Coast Hospital and Health Service, Southport, Queensland, Australia.

Brett G Mitchell (BG)

School of Nursing and Midwifery, Newcastle University, Callaghan, New South Wales, Australia.
School of Nursing, Avondale University College, Wahroonga, New South Wales, Australia.

Philip L Russo (PL)

Department of Nursing Research, Cabrini Institute, Malvern, Victoria, Australia.
Nursing and Midwifery, Monash University, Clayton, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH